Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Bufacchi, Antonella ^a   Nardiello, Barbara ^b   Capparella, Roberto ^a   Begnozzi, Luisa ^a  

^a SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anisotropic analytical algorithm; Dose volume histogram; Normal tissue complication probability; Pencil beam convolution algorithm

Indexed keywords

ADULT; ALGORITHM; ANISOTROPIC ANALYTICAL ALGORITHM; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DOSE CALCULATION; HEAD AND NECK CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; PENCIL BEAM CONVOLUTION ALGORITHM; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION RESPONSE; RECTUM HEMORRHAGE; RISK ASSESSMENT; STATISTICAL ANALYSIS; STUDENT T TEST; XEROSTOMIA;

ALGORITHMS; ANISOTROPY; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; PAROTID GLAND; PROBABILITY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK;

EID: 84879801600     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-164     Document Type: Article

References (63)

1. Arnfield MR, Siantar CH, Siembers J, Garmon P, Cox L, Mohan R. The impact of electron transport on the accuracy of computed dose. Med Phys 2000, 27:1266-74. 10.1118/1.599004, 10902555.
2. Carrasco P, Jornet N, Duch MA, Weber L, Ginjaume M, Eudaldo T, Jurado D, Ruiz A, Ribas M. Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium. Med Phys 2004, 31:2899-911. 10.1118/1.1788932, 15543799.
3. Shaine BH, Al-Ghazi MSAL, El-Khatib E. Experimental evaluation of interface doses in the presence of air cavities compared with treatment planning algorithms. Med Phys 1999, 26:350-5.
4. Engelsman M, Damen EMF, Koken PW, Van't Veld AA, Van Ingen KM, Mijnheer BJ. Impact of simple tissue inhomogneity correction algorithms on conformal radiotherapy of lung tumours. Radiother Oncol 2001, 60:299-09. 10.1016/S0167-8140(01)00387-5, 11514010.
5. AAPM Tissue inhomogeneity corrections for megavoltage photon beams 2004, New York: Report 85, AAPM.
6. Mackie TR, Scrimger JW, Battista JJ. A convolution method of calculating dose for 15 MV x rays. Med Phys 1985, 12:188-96. 10.1118/1.595774, 4000075.
7. Boyer AL, Mok EC. A photon dose distribution model employing convolution calculations. Med Phys 1985, 12:169-77. 10.1118/1.595772, 4000072.
8. Boyer AL, Mok EC. Calculation of photon dose distribution in an inhomogeneous medium using convolution. Med Phys 1986, 13:503-09. 10.1118/1.595964, 3090410.
9. Mohan R, Chui C, Lidofsky L. Differential pencil beam dose computation model for photons. Med Phys 1986, 13:64-73. 10.1118/1.595924, 3951411.
10. Woo MK, Cunningham JR. The validity of the density scaling method in primary electron transport for photon and electron beams. Med Phys 1990, 17:187-94. 10.1118/1.596497, 2333045.
11. Aspradakis MM, Morrison RH, Richmond ND, Steele A. Experimental verification of convolution/superposition photon dose calculation for radiotherapy treatment planning. Phys Med Biol 2003, 48:2873-93. 10.1088/0031-9155/48/17/309, 14516106.
12. Ulmer W, Pyyry J, Kaissl W. 3D photon superposition/convolution algorithm and its foundation on results of Monte Carlo calculations. Phys Med Biol 2005, 50:1767-90. 10.1088/0031-9155/50/8/010, 15815095.
13. Bragg CM, Wingate K, Conway J. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. Radiother Oncol 2008, 86:276-84. 10.1016/j.radonc.2008.01.011, 18249453.
14. Van Esch A, Tillikainen L, Pyykkonen J, Tenhunen M, Helminen H, Siljamäki S, Alakuijala J, Paiusco M, Lori M, Huyskens DP. Testing of the Analytical Anisotropic Algorithm for photon dose calculation. Med Phys 2006, 33:4130-48. 10.1118/1.2358333, 17153392.
15. Fogliata A, Nicolini G, Vanetti E, Clivio A, Cozzi L. Dosimetric validation of the anisotropic analytical algorithm for photon dose calculation: fundamental characterization in water. Phys Med Biol 2006, 51:1421-38. 10.1088/0031-9155/51/6/004, 16510953.
16. Knöös T, Wieslander E, Cozzi L, Brink C, Fogliata A, Albers D, Nyström H, Lassen S. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 2006, 51:5785-07. 10.1088/0031-9155/51/22/005, 17068365.
17. Sterpin E, Tomsej M, De Smedt B, Reynaert N, Vynckier S. Monte Carlo evaluation of the AAA treatment planning algorithm in a heterogeneous multilayer phantom and IMRT clinical treatments for an Electa Sl25 Linear Accelerator. Med Phys 2007, 34:1665-77. 10.1118/1.2727314, 17555248.
18. Fogliata A, Nicolini G, Vanetti E, Clivio A, Winkler P, Cozzi L. The impact of photon dose calculation algorithms on expected dose dostributions in lungs under different respiratory phases. Phys Med Biol 2008, 53:2375-90. 10.1088/0031-9155/53/9/011, 18421117.
19. Bragg CM, Conway J. Dosimetric verification of the Anisotropic Analytical Algorithm for radiotherapy treatment planning. Radiother Oncol 2006, 81:315-23. 10.1016/j.radonc.2006.10.020, 17125862.
20. Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, Brink C. Influence of dose calculation algorithms on the predicted dose distributions and NTCP values for NSCLC patients. Med Phys 2011, 38:2412-18. 10.1118/1.3575418, 21776775.
21. Webb S, Nahum AE. A model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous disributions of dose and clonogenic cell density. Phys Med Biol 1993, 39:653-66.
22. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. J Radiat Oncol Biol Phys 1991, 21:137-46.
23. Burman C, Kutcher GJ, Emami B, Goiten M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991, 21:123-35.
24. De Jaeger K, Hoogeman MS, Engelsman M, Seppenwoolde Y, Damen EM, Mijnheer BJ, Boersma LJ, Lebesque JV. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. Radiother Oncol 2003, 69:1-10. 10.1016/S0167-8140(03)00195-6, 14597351.
25. Belderbos JS, De Jaeger K, Heemsbergen WD, Seppenwoolde Y, Baas P, Boersma LJ, Lebesque JV. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 2003, 66:119-26. 10.1016/S0167-8140(02)00377-8, 12648783.
26. Martin E, Deville C, Bonnetain F, Bosset M, Créhange G, Truc G, Naudy S, Maingon P. Intensity-modulated radiation therapy in head and neck cancer : prescribed dose, clinical challenges and results. Radiother Oncol 2007, 85:392-08. 10.1016/j.radonc.2007.10.045, 18036690.
27. ICRU report 62 Prescribing, recording and reporting photon beam therapy 1999, Supplement to ICRU report 50, ICRU report 62.
28. AAPM Report 55 Radiation treatment planning dosimetry verification 1995, New York, AAPM Report 55.
29. TRS-430 Commissioning and quality assurance of computerized planning systems for radiation treatment of cancer 2004, Vienna: IAEA, TRS-430.
30. Lyman JT, Wolbarst AB. Optimization of radiation therapy III: a method of assessing complication probabilities from dose volume histograms. Int J Radiat Oncol Biol Phys 1987, 13:103-9.
31. Kallman P, Agren A, Brahme A. Tumor and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992, 62:249-62. 10.1080/09553009214552071, 1355519.
32. Fowler JF, Chappel R, Ritter M. Is α/β for prostate tumors really low?. Int J Radiat Oncol Biol Phys 2001, 50:1021-31. 10.1016/S0360-3016(01)01607-8, 11429230.
33. Kal HB, van Gellekom MPR. How low is the α/β ratio for prostate cancer?. Int Radiat Oncol Biol Phys 2003, 57:1116-21.
34. Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Incorporating clinical measurements of hypoxia into tumor local control modelling for prostate cancer: implications for the a/b ratio. Int Radiat Oncol Biol Phys 2003, 57:391-401.
35. Valdagni R, Italia C, Montanaro P, Lanceni A, Lattuada P, Magnani T, Fiorino C, Nahum A. Is the alpha-beta ratio for prostate cancer really low? A prospective, non randomized trial comparing standard and hypofractionated conformal radiation therapy. Radiather Oncol 2005, 75:74-82.
36. Fowler JF, Nahum AE, Orton CG. The best radiotherapy for the treatment of prostate cancer involves hypofractionation. Med Phys 2006, 33:3081-84. 10.1118/1.2179008, 17022199.
37. Nahum AE, Sanchez N. Tumor control probability modelling: basic principles and application in treatment planning. Phys Med 2001, 17:13-22.
38. Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2003, 55:724-35. 10.1016/S0360-3016(02)03986-X, 12573760.
39. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-12.
40. Ågren Cronqvist A-K Quantification of the response of heterogeneous tumors and organized normal tissue to fractionated radiotherapy 1995, Thesis. Stockholm University: Departement of Medical radiation Physics, Ågren Cronqvist A-K.
41. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume and function relationship in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999, 45:577-87. 10.1016/S0360-3016(99)00247-3, 10524409.
42. Roesink JM, Moerland MA, Hoekstra A, Van Rijk PP, Terhaard CH. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head and neck cancer: A prospective study of dose volume response relationship. Int J Radiat Oncol Biol Phys 2004, 58:1451-60. 10.1016/j.ijrobp.2003.09.021, 15050323.
43. Lawrence BM, Ellen DY, Andrew J, Randall KTH, Louis SC, Avraham E, Søren MB, Jiho N, Joseph OD. Use of normal tissue complication probability models in the clinic. Int Radiat Oncol Biol Phys 2010, 76:S10-S19.
44. Kong FM, Pan C, Eisbruch A, Haken RKT. Physical Models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol 2007, 17:108-120. 10.1016/j.semradonc.2006.11.007, 17395041.
45. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Lee AK, Cheung MR, Kuban DA, Cox JD, Mohan R. Fit of a generalized Lyman normal tissue complication probability (NTCP) model to grade ≥ 2 late rectal toxicity data from patients treated on protocol RTOG 94-06. Int J Radiat Oncol Biol Phys 2007, 69:S8-9.
46. Rancati T, Fiorino C, Vavassori V, Baccolini M, Bianchi C, Foppiano F, Menegotti L, Monti A, Pasquino M, Stasi M, Fellin G, Valdagni R. Late rectal bleeding after conformal radiotherapy for prostate cancer: NTCP modeling. Radiother Oncol 2008, 88:S332-3.
47. Söhn M, Yan D, Liang J, Meldolesi E, Vargas C, Alber M. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 2007, 67:1066-73. 10.1016/j.ijrobp.2006.10.014, 1991336, 17258870.
48. Morgan AM, Knöös T, McNee SG, Evans CJ, Thwaites DI. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol 2008, 86:48-54. 10.1016/j.radonc.2007.11.033, 18155309.
49. Schilstra C, Meertens H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. Int J Radiat Oncol Biol Phys 2001, 50:147-158. 10.1016/S0360-3016(00)01553-4, 11316558.
50. Brahme A. Optimized radiation therapy based on radiobiological objectives. Semin Radiat Oncol 1999, 9:35-47. 10.1016/S1053-4296(99)80053-8, 10196397.
51. Niemierko A, Urie M, Goiten M. Optimization of 3D radiation therapy with both physical and biological end points and constraints. Int J Radiat Oncol Biol Phys 1992, 23:99-107. 10.1016/0360-3016(92)90548-V, 1572836.
52. Stewart RD, Li XA. BGRT: Biologically guided radiation therapy - The future is fast approaching!. Med Phys 2007, 34:3739-51. 10.1118/1.2779861, 17985619.
53. Bentzen SM. Radiation therapy: Intensity modulated, image guided, biologically optimized and evidence based. Radiather Oncol 2005, 77:227-30.
54. Begg A, van der Kogel A. Clinical radiobiology in 2008. Radiother Oncol 2008, 86:295-299. 10.1016/j.radonc.2008.02.004, 18313778.
55. Chavaudra N, Bourhis J, Foray N. Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatic relaxation: a study of 19 human tumor cell lines from different origin. Radiother Oncol 2004, 73:373-82. 10.1016/j.radonc.2004.07.016, 15588885.
56. Hill RP, Kasper P, Griffin AM, O'Sullivan B, Catton C, Alasti H, Abbas A, Heydarian M, Ferguson P, Wunder JS, Bell RS. Studies of the in vivo radiosensitivity of human skin fibroblasts. Radiother Oncol 2007, 84:75-83. 10.1016/j.radonc.2007.05.025, 2034367, 17590467.
57. Martel MK, Sahijdak WM, Ten Haken RK, Kessler ML, Tumsi AT. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 1998, 40:155-61. 10.1016/S0360-3016(97)00584-1, 9422572.
58. Gagliardi G, Lax I, Ottolenghi A, Rutquist LE. Long-term cardiac mortality after radiotherapy of breast cancer-application of the relative seriality model. Br J Radiol 1996, 69:839-46. 10.1259/0007-1285-69-825-839, 8983588.
59. Eriksson F, Gagliardi G, Liedberg A, Lax I, Lee C, Levitt S, Lind B, Rutqvist LE. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 2000, 55:153-62. 10.1016/S0167-8140(00)00166-3, 10799727.
60. Kwa SL, Lebesgue JV, Theuws JCM, Marks LB, Munley MT, Bentel G, Oetzel D, Spahn U, Graham MV, Drzymala RE, Purdy JA, Lichter AS, Martel MK, Ten Haken RK. Radiation pneumonitis as a function of mean dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998, 42:1-9.
61. Gagliardi G, Bjöhle J, Lax I, Ottolenghi A, Eriksson F, Liedberg A, Lind P, Rutqvist LE. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000, 46:373-81. 10.1016/S0360-3016(99)00420-4, 10661344.
62. Rancati T, Fiorino C, Gagliardi G, Cattaneo GM, Sanguineti G. Casanova Borca V, Cozzarini C, Fellin G, Foppiano F, Girelli G, Menegotti L, Piazzolla A, Vavassori V, Valdagni R: Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 2004, 73:21-32. 10.1016/j.radonc.2004.08.013, 15465142.
63. Peeters ST, Hoogeman MS, Heemsbergen WD, Hart AA, Koper PC, Lebesque JV. Rectal bleeding, fecal incontinence and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 2006, 66:11-19. 10.1016/j.ijrobp.2006.03.034, 16757129.